OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
-14.92%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$497M
AUM Growth
+$497M
(-27%)
Cap. Flow
-$66.2M
Cap. Flow
% of AUM
-13.31%
Top 10 Holdings %
Top 10 Hldgs %
93.04%
Holding
32
New
6
Increased
4
Reduced
9
Closed
4
Top Buys
| 1 |
ARK Innovation ETF
ARKK
|
$16.6M |
| 2 |
GeneDx Holdings
WGS
|
$12.1M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$4.52M |
| 4 |
ImmunityBio
IBRX
|
$2.24M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$813K |
Top Sells
| 1 |
Vir Biotechnology
VIR
|
$36.1M |
| 2 |
Pfizer
PFE
|
$28M |
| 3 |
QuidelOrtho
QDEL
|
$16.5M |
| 4 |
Opko Health
OPK
|
$11.1M |
| 5 |
AWH
Aspira Women's Health Inc. Common Stock
AWH
|
$3.57M |
Sector Composition
| 1 | Healthcare | 96.56% |
| 2 | Energy | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $244M | 48.33% | 2,061,402 -14,000 | -0.7% | -$1.66M |
|
|
2
QuidelOrtho
QDEL
$1.95B
| $79.7M | 15.76% | 708,631 -146,437 | -17% | -$16.5M |
|
|
3
Opko Health
OPK
$1.1B
| $30.9M | 6.11% | 8,985,756 -3,233,317 | -26% | -$11.1M |
|
|
4
BioCryst Pharmaceuticals
BCRX
$1.74B
| $28M | 5.53% | 1,720,733 +50,000 | +3% | +$813K |
|
|
AGEN
5
Agenus
AGEN
$133M
| $21.4M | 4.24% | 8,706,132 -400,000 | -4% | -$984K |
|
|
6
ARK Innovation ETF
ARKK
$7.45B
| $16.6M | 3.28% | +250,000 | New | +$16.6M |
|
|
7
GeneDx Holdings
WGS
$3.72B
| $12.1M | 2.39% | +3,944,832 | New | +$12.1M |
|
8
Pacific Biosciences
PACB
$393M
| $11.2M | 2.21% | 1,225,395 -195,257 | -14% | -$1.78M |
|
|
DMTK
9
DELISTED
DermTech, Inc. Common Stock
DMTK
| $9.59M | 1.9% | 652,907 +50,000 | +8% | +$734K |
|
10
Forian
FORA
$61.3M
| $8.78M | 1.74% | 1,262,040 +42,379 | +3% | +$295K |
|
|
CFRX
11
DELISTED
ContraFect Corporation
CFRX
| $7.13M | 1.41% | 1,954,222 +1,800 | +0.1% | +$6.57K |
|
|
ATRS
12
DELISTED
Antares Pharma, Inc.
ATRS
| $7.05M | 1.39% | 1,720,000 | – | – |
|
|
13
Acadia Pharmaceuticals
ACAD
$4.38B
| $4.52M | 0.89% | +186,789 | New | +$4.52M |
|
|
AXDX
14
DELISTED
Accelerate Diagnostics
AXDX
| $3.93M | 0.78% | 2,731,856 -895,693 | -25% | -$1.29M |
|
|
CDAK
15
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $3.16M | 0.63% | 504,602 -154,589 | -23% | -$969K |
|
|
IMMP
16
Immutep
IMMP
$234M
| $2.68M | 0.53% | 976,156 | – | – |
|
|
17
ImmunityBio
IBRX
$2.21B
| $2.24M | 0.44% | +400,013 | New | +$2.24M |
|
|
AWH
18
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $2.2M | 0.44% | 2,116,839 -3,430,255 | -62% | -$3.57M |
|
|
VTNR
19
DELISTED
Vertex Energy, Inc
VTNR
| $547K | 0.11% | +55,000 | New | +$547K |
|
20
Biogen
BIIB
$19.4B
| $508K | 0.1% | 2,412 | – | – |
|
21
Soleno Therapeutics
SLNO
$3.6B
| $475K | 0.09% | 2,132,000 | – | – |
|
22
Arbutus Biopharma
ABUS
$711M
| $149K | 0.03% | +50,000 | New | +$149K |
|
23
Performance Technologies
PTIX
$3.13M
| $16K | ﹤0.01% | 20,000 -280,267 | -93% | -$224K |
|
24
ARK Genomic Revolution ETF
ARKG
$1.04B
| – | – | 0 | – | – |
|
25
Cross Country Healthcare
CCRN
$438M
| – | – | -71,000 | Closed | -$1.97M |
|